Cargando…
Plasma-Induced Catalyst Support Defects for the Photothermal Methanation of Carbon Dioxide
The presence of defects in a catalyst support is known to benefit catalytic activity. In this work, a He-plasma treatment-based strategy for introducing and stabilising defects on a Ni/TiO(2) catalyst for photothermal CO(2) hydrogenation was established. The impact of pretreatment step sequence—whic...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347005/ https://www.ncbi.nlm.nih.gov/pubmed/34361399 http://dx.doi.org/10.3390/ma14154195 |
Sumario: | The presence of defects in a catalyst support is known to benefit catalytic activity. In this work, a He-plasma treatment-based strategy for introducing and stabilising defects on a Ni/TiO(2) catalyst for photothermal CO(2) hydrogenation was established. The impact of pretreatment step sequence—which comprised He-plasma treatment and reduction/passivation—on defect generation and stabilisation within the support was evaluated. Characterisation of the Ni/TiO(2) catalysts indicated that defects created in the TiO(2) support during the initial plasma treatment stage were then stabilised by the reduction/passivation process, (P-R)Ni/TiO(2). Conversely, performing reduction/passivation first, (R-P)Ni/TiO(2), invoked a resistance to subsequent defect formation upon plasma treatment and consequently, poorer photothermal catalytic activity. The plasma treatment altered the metal-support interaction and ease of catalyst reduction. Under photothermal conditions, (P-R)Ni/TiO(2) reached the highest methane production in 75 min, while (R-P)Ni/TiO(2) required 165 min. Decoupling the impacts of light and heat indicated thermal dominance of the reaction with CO(2) conversion observed from 200 °C onwards. Methane was the primary product with carbon monoxide detected at 350 °C (~2%) and 400 °C (~5%). Overall, the findings demonstrate the importance of pretreatment step sequence when utilising plasma treatment to generate active defect sites in a catalyst support. |
---|